I just called into a meeting that EYE curated back in 2018 after interest in Coronaviruses got low. People were leaving our meetings so I rebranded it as the “emerging infectious diseases” meeting. When the pandemic started interest went up and it became a center-wide meeting.
The meeting today ended with “okay which principal investigator will take over”. It’s extremely hard to leave your baby behind… but… you know…
Go where you are loved. x My Dad
In an attempt to go where there is love for my faculty position, I narrowed my options down to places where I felt I would be loved. Community and vibes are so important to me.
I made the departments recruiting me know that very early on. And, so many universities (& companies actually) went above and beyond to help me (over 9 months) feel the vibe of their institution.
As a PI at their institution, moreover. I was treated like I already had a seat at their tables. But, what about community outside of the walls of the institution???
My 2nd looks (when you visit the 2nd time more relaxed cause now no one is drilling you about your 10 year plan lol) were amazing across the board, but @HarvardChanSPH brought me to Boston and sold me on the community within academia and Boston as a whole.
Today, my dad and my PhD dad get to witness me getting an honorary degree from UNC. I didn’t “walk” after defending my dissertation. So today... I walk.
So many full circle moments this year.
Honored.
1/n: I hope that no one to which I owe manuscript edits is reading this, but I felt a thread on my spirit as I listened to my UNC commencement address entitled "Home". instagram.com/tv/CPEMTyPHthd…
2/n: I just got an honorary doctorate from the institution (@unc) that I also received my PhD in Microbiology and Immunology in 2014. I cried during my "thank you", and I cried when I defended my dissertation, and I cried when @HarvardChanSPH announced my faculty appt last wk.
“She was also involved in several extracurricular activities, including serving as a representative on Student Congress, a delegate to the Association of Student Governments, a staff member in the Attorney General’s office and as a member of the science policy advisory group.”
This quote is a reminder to all students far and wide to not allow anyone to put you in a box. You are not “just” a PhD student. You are a citizen first. Do you, Boo.
1/n: I had to forego the only midday nap I’ve had in over a yr yesterday to address my @instagram DMs b/c so many are hurriedly writing about vaccine dosing, w/o remembering the current dosing is great, safe, effective AND (surprise) public trust matters. instagram.com/stories/kizzyp…
2/n: We understand things can change for science-driven efficiency. Would delaying a second dose be “ok”, probs; but ppl know about efficacy data from the current schedule. I'm often scrambling to find solid data to match X scientist's op ed so of course lay ppl are confused af.
3/n: Remember how confused ppl were when masks were first deemed not needed then suddenly science suggested that in fact they are?! That was us (scientists) on our high horses, not waiting for the data to policy circle to be completed. Just stop!
1/n: Good morning esp. to our animal techs, who bled ~200 mice last yr on this day. It was the 2-wk post-prime timepoint, & we just had to peek at the antibody responses.
Do you think they knew those mice had gotten the vaccine they would themselves get only a year later? 💉 ❤️
2/n: We’d immunized 3 mouse strains, w/ multiple doses of mRNA-1273 to not just be prepared to show protection (ala @Baric_Lab@SarahRLeist), but also to be prepared to show that sub-protection was not a cause for vaccine-induced enhancement.
3/n: These figs never make it into my talks cause who care about mice when u have 94.1% human efficacy?
So fig. 2 (nature.com/articles/s4158…) shows IgG antibodies that bind the SARS-CoV-2 spike protein 2 wks after the 1st dose, particularly in the modestly-high dose (1 ug) groups.
1/n: I’m about to use this morning’s “woke up in a panic ‘cause my ‘to do’ list is longer than my day” rant to address this consistent and *flawed* argument
2/n: Because I work at the center that the Clinton Administration erected in with the purpose of developing a HIV vaccine, I’m privileged to have watched HIV vaccine development from “point A” to ummmm let’s say ‘bout “point M” over the years.
3/n: Which is darn good, considering HIV is so genetically diverse, a retrovirus, decorated in glycans, hides from immunity, probs needs a little more than “just” antibodies, etc etc etc
1/n: People are asking me for comments, and I'll tell you how my ex project manager used to tell me re: me overachieving & striving for "perfection" in some things...
"Don't let the perfect get in the way of the good enough."
This is darn good for 1-dose ... "in a pandemic".
2/n: I feared that actually... that ppl would be spoiled by mRNA and any vaccine to come after would be looked at as "lesser than". Vaccines are being transformed in front of all of our eyes, but science is going to science...
3/n: ...and the fact that science is producing multiple good-enough candidates with utilities in various niches of global acceptance/distribution/pricing/etc in only a year is...